Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Value · Franklin Templeton

ClearBridge Value Fund Class A (LGVAX)

Ticker LGVAX · · Holdings as of Jul 31, 2026

Expense ratio
1.01%$101/yr per $10k
5-yr return
+11.4%annualized
1-yr return
+4.4%as of Dec 2025
Net assets
$4.3Ball share classes
Holdings
67

Bottom line

Is LGVAX a good fund? The bottom line

LGVAX is the Class A share class of ClearBridge Value Fund, an actively managed large value mutual fund from Franklin Templeton.

It charges 1.01% — about $101 a year on every $10,000 invested, more expensive than 68% of large value funds we track.

It returned +4.4% over one year, +11.4% a year over five years, +10.5% a year over ten (as of Dec 31, 2025, per its prospectus).

With $4.3 billion in net assets and 67 holdings, its largest position is Amazon.com Inc (7.6%) and the top 10 make up 32.5% of the portfolio.

This share class carries a front-end sales charge of up to 5.5%; a no-load class or ETF alternative can avoid it.

What to watch

  • Front-end sales load up to 5.5%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What LGVAX invests in

Long-term growth of capital.

The fund invests primarily in equity securities that, in the portfolio managers opinion, offer the potential for capital growth. The portfolio managers follow a value discipline in selecting securities, and therefore seek to purchase securities at large discounts to the portfolio managers assessment of the issuers intrinsic value. Intrinsic value, according to the portfolio managers, is the value of the company measured, to different extents depending on the type of company, on factors such as, but not limited to, the discounted value of its projected future free cash flows, the companys ability to earn returns on capital in excess of its cost of capital, private market values of similar companies and the costs to replicate the business. The portfolio managers take a long-term approach to investing. The fund generally invests in companies with market capitalizations greater than $5…

From the fund's prospectus (filed Feb 24, 2026).

LGVAX performance

Average annual total returns
1 yr5 yr10 yr
LGVAX+4.4%+11.4%+10.5%
Large Value median+13.6%+11.3%+10.2%

Source: Fund prospectus, as of Dec 31, 2025

Full LGVAX performance history →

What LGVAX costs

On a $10,000 investment, LGVAX's 1.01% expense ratio costs about $101 a year. The prospectus estimates $1,749 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full LGVAX fee table →

LGVAX top 10 holdings

#Holding% of fund
1Amazon.com Inc AMZN7.65%
2Apple Inc AAPL4.89%
3Bank Of America Corp BAC3.93%
4Johnson & Johnson JNJ3.01%
5Chevron Corp CVX2.77%
6Conocophillips COP2.33%
7Unitedhealth Group Inc UNH2.19%
8Cvs Health Corp CVS1.96%
9Block Inc XYZ1.91%
10Diamondback Energy Inc FANG1.91%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 32.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to LGVAX

More funds like LGVAX →

LGVAX FAQ

What is the expense ratio of LGVAX?
LGVAX's expense ratio is 1.01%, which works out to about $101 a year for every $10,000 invested. The prospectus estimates total costs of $1,749 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is LGVAX a good investment?
It depends on your goals, but the data points to: front-end sales load up to 5.5%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does LGVAX hold?
LGVAX's largest holdings are Amazon.com Inc (7.6%), Apple Inc (4.9%), Bank Of America Corp (3.9%), Johnson & Johnson (3.0%), Chevron Corp (2.8%). It holds 67 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is LGVAX's 5-year return?
LGVAX returned +11.4% a year over the five years ending Dec 31, 2025, and +10.5% a year over ten years. Past performance does not guarantee future results.
Does LGVAX have a sales load?
Yes. LGVAX has a maximum front-end sales charge of 5.5%.
Who manages LGVAX?
LGVAX is offered by Franklin Templeton through Legg Mason Global Asset Management Trust.